ASP Isotopes Inc. (W62)
XMUN 
Summary
W62 Chart
ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth
ASP Isotopes NASDAQ: ASPI expects several of its business units to enter commercial production or expand output over the next six months, with Chief Executive Officer Paul Mann highlighting progress in helium, liquefied natural gas, stable isotopes and radiopharmaceuticals during a conference presentation.
ASP Isotopes Targets 2026 Deliveries as Helium, Radiopharmacy Expansion Gains Speed
ASP Isotopes NASDAQ: ASPI outlined plans to expand its isotope production, radiopharmacy and helium businesses during Canaccord Genuity's 46th Annual Growth Conference, with commercial deliveries of several stable isotopes targeted for the second half of 2026.
ASP Isotopes Inc. (ASPI) Discusses Noble Africa's Merger Plans and Strategy to Become a Publicly Traded Helium Platform Transcript
ASP Isotopes Inc. (ASPI) Discusses Noble Africa's Merger Plans and Strategy to Become a Publicly Traded Helium Platform Transcript
ASP Isotopes Inc. (W62) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has ASP Isotopes Inc. ever had a stock split?
ASP Isotopes Inc. Profile
| Chemicals Industry | Materials Sector | Paul Elliot Mann CEO | XMUN Exchange | US00218A1051 ISIN |
| US Country | 271 Employees | - Last Dividend | - Last Split | 10 Nov 2022 IPO Date |
Overview
ASP Isotopes Inc. is a development stage advanced materials company established in 2021, based in Washington, District Of Columbia. The company specializes in the production, distribution, marketing, and sale of isotopes. At the forefront of its operations, ASP Isotopes Inc. is dedicated to the innovation and commercialization of essential isotopes for various industries, including the medical sector. It focuses on leveraging cutting-edge Quantum Enrichment technology to produce a range of isotopes, asserting itself as a pivotal player in the advanced materials industry.
Products and Services
- Molybdenum-100:
ASP Isotopes Inc. engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope. This particular isotope is primarily aimed at the medical industry, where it is used in various applications, indicating the company's contribution to healthcare advancements.
- Carbon-14:
Aside from Molybdenum-100, the company also focuses on the production of Carbon-14. This isotope has widespread uses, including in biomedical research, environmental science, and radiocarbon dating, showcasing ASP Isotopes Inc.'s commitment to supporting scientific research and development.
- Silicon-28:
Silicon-28 is another key product of ASP Isotopes Inc., underlining the company’s versatility in producing isotopes for varied applications. While the specific uses of Silicon-28 by the company are not detailed, Silicon-28 has significant potential in electronics and quantum computing, sectors which demand ultra-pure materials for innovation.
- Developing Isotopes with Quantum Enrichment Technology:
The company is at the forefront of developing Quantum Enrichment technology to produce a range of isotopes, including Ytterbium-176, Nickel-64, Lithium 6, Lithium 7, and Uranium-235. This innovative approach highlights ASP Isotopes Inc.’s role in advancing the technology used for isotope production, aiming to serve various sectors including medical, industrial, and energy, by providing high-purity isotopes crucial for diverse applications.
